|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fogel EL, Shahda S, Sandrasegaran K,
DeWitt J, Easler JJ, Agarwal DM, Eagleson M, Zyromski NJ, House MG,
Ellsworth S, et al: A multidisciplinary approach to pancreas cancer
in 2016: A review. Am J Gastroenterol. 112:537–554. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stedman KE, Moore GE and Morgan RT:
Estrogen receptor proteins in diverse human tumors. Arch Surg.
115:244–248. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hwang KA, Park SH, Yi BR and Choi KC: Gene
alterations of ovarian cancer cells expressing estrogen receptors
by estrogen and bisphenol a using microarray analysis. Lab Anim
Res. 27:99–107. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeung EB and Choi KC: Toxicological
mechanism of endocrine disrupting chemicals: Is estrogen receptor
involved? Toxicol Res. 26:237–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park MA, Hwang KA and Choi KC: Diverse
animal models to examine potential role(s) and mechanism of
endocrine disrupting chemicals on the tumor progression and
prevention: Do they have tumorigenic or anti-tumorigenic property?
Lab Anim Res. 27:265–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schug TT, Janesick A, Blumberg B and
Heindel JJ: Endocrine disrupting chemicals and disease
susceptibility. J Steroid Biochem Mol Biol. 127:204–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roy JR, Chakraborty S and Chakraborty TR:
Estrogen-like endocrine disrupting chemicals affecting puberty in
humans-a review. Med Sci Monit. 15:RA137–RA145. 2009.PubMed/NCBI
|
|
9
|
Kang NH, Hwang KA, Kim TH, Hyun SH, Jeung
EB and Choi KC: Induced growth of BG-1 ovarian cancer cells by
17β-estradiol or various endocrine disrupting chemicals was
reversed by resveratrol via downregulation of cell cycle
progression. Mol Med Rep. 6:151–156. 2012.PubMed/NCBI
|
|
10
|
Kim SH, Nam KH, Hwang KA and Choi KC:
Influence of hexabromocyclododecane and 4-nonylphenol on the
regulation of cell growth, apoptosis and migration in prostatic
cancer cells. Toxicol In Vitro. 32:240–247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang X, Huang H, Wang M, Zheng X, Xu J and
Xie M: Effect of nonylphenol on the regulation of cell growth in
colorectal cancer cells. Mol Med Rep. 16:2211–2216. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mellor H and Parker PJ: The extended
protein kinase C superfamily. Biochem J. 332:281–292. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao S, Bee A, Brewer D, Dodson A, Beesley
C, Ke Y, Ambroisine L, Fisher G, Møller H, Dickinson T, et al:
PRKC-ζ expression promotes the aggressive phenotype of human
prostate cancer cells and is a novel target for therapeutic
intervention. Genes Cancer. 1:444–464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo H, Gu F, Li W, Zhang B, Niu R, Fu L,
Zhang N and Ma Y: Reduction of protein kinase C zeta inhibits
migration and invasion of human glioblastoma cells. J Neurochem.
109:203–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang S, Ouyang N, Lin L, Chen L, Wu W, Su
F, Yao Y and Yao H: HGF-induced PKCζ activation increases
functional CXCR4 expression in human breast cancer cells. PLoS One.
7:e291242012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luna-Ulloa LB, Hernández-Maqueda JG,
Santoyo-Ramos P, Castañeda-Patlán MC and Robles-Flores M: Protein
kinase C ζ is a positive modulator of canonical Wnt signaling
pathway in tumoral colon cell lines. Carcinogenesis. 32:1615–1624.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YS, Hwang KA, Hyun SH, Nam KH, Lee CK
and Choi KC: Bisphenol A and nonylphenol have the potential to
stimulate the migration of ovarian cancer cells by inducing
epithelial-mesenchymal transition via an estrogen receptor
dependent pathway. Chem Res Toxicol. 28:662–671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park MA and Choi KC: Effects of
4-nonylphenol and bisphenol A on stimulation of cell growth via
disruption of the transforming growth factor-β signaling pathway in
ovarian cancer models. Chem Res Toxicol. 27:119–128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang L, Shen H, Li X, Li Z, Liu Z, Xu J,
Ma S, Zhao X, Bai X, Li M, et al: MiR-125a-5p decreases after long
non-coding RNA HOTAIR knockdown to promote cancer cell apoptosis by
releasing caspase 2. Cell Death Dis. 7:e21372016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonefeld-Jørgensen EC, Long M, Hofmeister
MV and Vinggaard AM: Endocrine-disrupting potential of bisphenol A,
bisphenol A dimethacrylate, 4-n-nonylphenol and 4-n-octylphenol in
vitro: New data and a brief review. Environ Health Perspect. 115
Suppl 1:S69–S76. 2007. View
Article : Google Scholar
|
|
21
|
In SJ, Kim SH, Go RE, Hwang KA and Choi
KC: Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer
growth by regulating cell cycle and metastasis-related genes via an
estrogen receptor alpha-dependent pathway. J Toxicol Environ Health
A. 78:492–505. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim SH, Hwang KA, Shim SM and Choi KC:
Growth and migration of LNCaP prostate cancer cells are promoted by
triclosan and benzophenone-1 via an androgen receptor signaling
pathway. Environ Toxicol Pharmacol. 39:568–576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu C, Sun Y, Song Y, Saito T and Kurasaki
M: Nonylphenol diethoxylate inhibits apoptosis induced in PC12
cells. Environ Toxicol. 31:1389–1398. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stamatakos M, Palla V, Karaiskos I,
Xiromeritis K, Alexiou I, Pateras I and Kontzoglou K: Cell cyclins:
Triggering elements of cancer or not? World J Surg Oncol.
8:1112010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roy A and Banerjee S: p27 and leukemia:
Cell cycle and beyond. J Cell Physiol. 230:504–509. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sandhu C and Slingerland J: Deregulation
of the cell cycle in cancer. Cancer Detect Prev. 24:107–118.
2000.PubMed/NCBI
|
|
27
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.PubMed/NCBI
|
|
28
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Butler AM, Scotti Buzhardt ML, Li S, Smith
KE, Fields AP and Murray NR: Protein kinase C zeta regulates human
pancreatic cancer cell transformed growth and invasion through a
STAT3-dependent mechanism. PLoS One. 8:e720612013. View Article : Google Scholar : PubMed/NCBI
|
